These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38516383)

  • 1. Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
    Kramer TS; Soriano A; Tedeschi S; Chen AF; Tattevin P; Senneville E; Gomez-Junyent J; Birlutiu V; Petersdorf S; de Brito VD; Gonzalez IS; Belden KA; Wouthuyzen-Bakker M
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae075. PubMed ID: 38516383
    [No Abstract]   [Full Text] [Related]  

  • 2. Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
    Kramer TS; Soriano A; Tedeschi S; Chen AF; Tattevin P; Senneville E; Gomez-Junyent J; Birlutiu V; Petersdorf S; de Brito VD; Gonzalez IS; Belden KA; Wouthuyzen-Bakker M
    Open Forum Infect Dis; 2023 Oct; 10(10):ofad491. PubMed ID: 37901121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study.
    Open Forum Infect Dis; 2024 Feb; 11(2):ofad602. PubMed ID: 38375505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RE: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study by Kramer et al.
    Rieber H
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae074. PubMed ID: 38516382
    [No Abstract]   [Full Text] [Related]  

  • 5. Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin.
    Eriksson HK; Lazarinis S; Järhult JD; Hailer NP
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of enteric bacteria as cause of periprosthetic joint infections in patients with liver cirrhosis.
    Koepf US; Scheidt S; Hischebeth GTR; Strassburg CP; Wirtz DC; Randau TM; Lutz P
    BMC Infect Dis; 2022 Apr; 22(1):389. PubMed ID: 35439971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?
    Wouthuyzen-Bakker M; Scheper H
    Expert Rev Anti Infect Ther; 2023; 21(7):695-701. PubMed ID: 37141111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients.
    Manning L; Metcalf S; Clark B; Robinson JO; Huggan P; Luey C; McBride S; Aboltins C; Nelson R; Campbell D; Solomon LB; Schneider K; Loewenthal M; Yates P; Athan E; Cooper D; Rad B; Allworth T; Reid A; Read K; Leung P; Sud A; Nagendra V; Chean R; Lemoh C; Mutalima N; Grimwade K; Sehu M; Torda A; Aung T; Graves S; Paterson D; Davis J
    Open Forum Infect Dis; 2020 May; 7(5):ofaa068. PubMed ID: 32432148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients.
    Lazarinis S; Hailer NP; Järhult JD; Brüggemann A
    Antibiotics (Basel); 2023 Sep; 12(10):. PubMed ID: 37887200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.
    Wouthuyzen-Bakker M; Sebillotte M; Lomas J; Kendrick B; Palomares EB; Murillo O; Parvizi J; Shohat N; Reinoso JC; Sánchez RE; Fernandez-Sampedro M; Senneville E; Huotari K; Allende JMB; García AB; Lora-Tamayo J; Ferrari MC; Vaznaisiene D; Yusuf E; Aboltins C; Trebse R; Salles MJ; Benito N; Vila A; Toro MDD; Kramer TS; Petersdorf S; Diaz-Brito V; Tufan ZK; Sanchez M; Arvieux C; Soriano A;
    J Infect; 2019 Sep; 79(3):199-205. PubMed ID: 31319141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
    BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection.
    Svensson Malchau K; Tillander J; Zaborowska M; Hoffman M; Lasa I; Thomsen P; Malchau H; Rolfson O; Trobos M
    J Orthop Translat; 2021 Sep; 30():31-40. PubMed ID: 34485075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of pathogen distribution in patients with fracture-related infection and periprosthetic joint infection: a retrospective study.
    Ma T; Lyu J; Ma J; Huang X; Chen K; Wang S; Wei Y; Shi J; Xia J; Zhao G; Huang G
    BMC Musculoskelet Disord; 2023 Feb; 24(1):123. PubMed ID: 36782133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients.
    Davis JS; Metcalf S; Clark B; Robinson JO; Huggan P; Luey C; McBride S; Aboltins C; Nelson R; Campbell D; Solomon LB; Schneider K; Loewenthal MR; Yates P; Athan E; Cooper D; Rad B; Allworth T; Reid A; Read K; Leung P; Sud A; Nagendra V; Chean R; Lemoh C; Mutalima N; Tran T; Grimwade K; Sehu M; Looke D; Torda A; Aung T; Graves S; Paterson DL; Manning L
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac048. PubMed ID: 35233433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
    Thill P; Robineau O; Roosen G; Patoz P; Gachet B; Lafon-Desmurs B; Tetart M; Nadji S; Senneville E; Blondiaux N
    J Antimicrob Chemother; 2022 Mar; 77(4):1036-1040. PubMed ID: 35028671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.
    Morata L; Senneville E; Bernard L; Nguyen S; Buzelé R; Druon J; Tornero E; Mensa J; Soriano A
    Infect Dis Ther; 2014 Dec; 3(2):235-43. PubMed ID: 25139552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term complications have more effect on cost-effectiveness of THA than implant longevity.
    Shearer DW; Youm J; Bozic KJ
    Clin Orthop Relat Res; 2015 May; 473(5):1702-8. PubMed ID: 25560958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for periprosthetic ankle joint infection: a case-control study.
    Kessler B; Sendi P; Graber P; Knupp M; Zwicky L; Hintermann B; Zimmerli W
    J Bone Joint Surg Am; 2012 Oct; 94(20):1871-6. PubMed ID: 23079879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Acute Periprosthetic Infections with DAIR (Debridement, Antibiotics and Implant Retention) - Success Rate and Risk Factors of Failure].
    Abrman K; Musil D; Stehlík J
    Acta Chir Orthop Traumatol Cech; 2019; 86(3):181-187. PubMed ID: 31333181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.